Ledger.Open graph →
SEC Form D · filed September 4, 2024

Evogene Ltd

Offering
$12.0M
Sold
—
Exemption
Rule 506(b)
Industry
Other
Location
REHOVOT, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Nir Nimrodi · San Jose, CADirectorSarit Firon · Rehovot, L3DirectorYaron Eldad · Rehovot, L3ExecDan Falk · Kfar Saba, L3DirectorAdrian Percy · Rehovot, L3DirectorOfer Haviv · Rehovot, L3ExecLeon Y. Recanati · Rehovot, L3DirectorNir Nimrodi · San Jose, CADirectorSarit Firon · Rehovot, L3DirectorYaron Eldad · Rehovot, L3ExecEyal Ronen · Rehovot, L3ExecDan Falk · KFAR NETTER, L3DirectorSassi Masliah · Rehovot, L3ExecOded Y. Shoseyov · Rehovot, L3DirectorAdrian Percy · Rehovot, L3DirectorOfer Haviv · Rehovot, L3ExecLeon Y. Recanati · Rehovot, L3DirectorMark Kapel · Rehovot, L3ExecMukesh K. Chhaganlal · SINGAPORE, U0DirectorDouglas Johnston · Pittsburgh, PADirectorMichael Chancellor · Pittsburgh, PAExecLori Birder · Pittsburgh, PADirectorDaniel Cohen · Pittsburgh, PADirectorRyan Carter · Eastvale, CAExecJonathan Kaufman · Pittsburgh, PADirectorEyal Ronen · Rehovot, L3ExecSassi Masliah · Rehovot, L3ExecOded Y. Shoseyov · Rehovot, L3DirectorMark Kapel · Rehovot, L3Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗